Developmental aspects of epileptogenesis

Epilepsia

Volumn 37, Issue SUPPL. 1, 1996, Pages

  Johnston, Michael V ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Developmental biology; Epilepsy; Kindling; Neurological models; Neuroregulators; Neurotransmitter uptake inhibitors; Synaptic receptors

Indexed keywords

BIOGENIC AMINE; EXCITATORY AMINO ACID RECEPTOR; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

BRAIN DEVELOPMENT; EPILEPSY; EPILEPTOGENESIS; HIPPOCAMPUS; HUMAN; KINDLING; LONG TERM POTENTIATION; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0029982539     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb06018.x     Document Type: Review

References (64)

1. Moshé SL, Cornblath M. Developmental aspects of epileptogenesis. In: Wyllie E, ed. The treatment of epilepsy, principles and practice. Philadelphia: Lea & Febiger, 1993:99-110.
2. Schwartzkroin PA. Basic mechanisms of epileptogenesis. In: Wyllie E, ed. The treatment of epilepsy, principles and practice. Philadelphia: Lea & Febiger, 1993:83-98.
3. Huttenlocher PR, Courten C. The development of synapses in striate cortex of man. Hum Neurobiol 1987;6:1-9.
4. Kraus JE, Bonhaus DE, Nadler JV, McNamara JO. Kindling induces the long-lasting expression of a novel population of NMDA receptors in hippocampal region CA3. J Neurosci 1994;14:4196-205.
5. McDonald JW, Johnston MV. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Brain Res Rev 1990; 15:41-70.
6. Burgard EC, Habitz JJ. Developmental changes in NMDA and non-NMDA receptor-mediated synaptic potentials in rat neocortex. J Neurophysiol 1993;69:230-40.
7. Morrisett RA, Mott DD, Lewis DV, Wilson WA, Swartzwelder HS. Reduced sensitivity of the NMDA component of synaptic transmission to magnesium in hippocampal slices from immature rats. Brain Res Dev Brain Res 1990;56:257-62.
8. 2+ block of NMDA receptor-mediated synaptic potentials in developing visual cortex. Proc Natl Acad Sci USA 1993;90:7114-8.
9. Williams K, Romano C, Dichter MA, Molinoff PB. Modulation of the NMDA receptor by polyamines. Life Sci 1991; 48:469-98.
10. Sheng M, Cummings J, Rolau LA, Jan YN, Jan LY. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 1994;368:144-7.
11. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. Development and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529-40.
12. Tremblay E, Roisin MP, Represa A, Charriaut-Marlangue, Ben-Ari Y. Transient increased density of NMDA binding sites in the developing rat hippocampus. Brain Res 1988;461: 393-6.
13. McDonald JW, Johnston MV, Young AB. Differential ontogenic development of three receptors comprising the NMDA receptor/channel complex in the rat hippocampus. Exp Neurol 1990;110:237-47.
14. Nicoletti F, Iadarola MJ, Wroblewski JT, Costa E. Excitatory amino acid recognition sites coupled with inosital phospholipid metabolism: developmental changes and interaction with μ-adrenoreceptors. Proc Natl Acad Sci USA 1986;83:1931-5.
15. Bear MF, Dudek SM. Stimulation of phosphoinositide turnover by excitatory amino acids. Pharmacology, development and role in visual cortical plasticity. Ann NY Acad Sci 1991;627:42-56.
16. Blue ME, Johnston MV. The ontogeny of glutamate receptors in rat barrel field cortex. Brain Res Dev Brain Res 1995; 84:11-25.
17. McDonald JW, Trescher WH, Chen C-K, Johnston MV. Susceptibility of brain to AMPA induced neurotoxicity transiently peaks during early postnatal development. Brain Res 1992;583:54-70.
18. Schoepp D, Johnson BG, Solhoff CR, McDonald JW, Johnston MV. In vivo and in vitro pharmacology of trans and cis-ACPD: dissociation of metabotropic and ionotropic amino acid receptor effects. J Neurochem 1991;56:1789-96.
19. Trescher WH, McDonald JW, Johnston MV. Quinolinate induced injury is enhanced in developing rat brain. Brain Res Dev Brain Res 1994;83:224-32.
20. 4 afferents with kainic acid. Brain Res 1980; 182:1-9.
21. Sutula T, Xiao-Xian H, Cavazos J, Grayson S. Synaptic reorganization in the hippocampus induced by abnormal functional activity. Science 1988;239:1147-50.
22. Olney JW, deGubareff T, Sloviter RS. Epileptic brain damage in rats induced by sustained electrical stimulation of the perforant path. II: Ultrastructural analysis of acute hippocampal pathology. Brain Res Bull 1983;10:699-712.
23. Mathern GW, Pretorius JK, Baler TL. Quantified patterns of mossy fiber sprouting and neuron densities in hippocampal and lesional seizures. J Neurosurg 1995;82:211-9.
24. Brady RJ, Swann JW. Ketamine selectively suppresses synchronous discharges in immature hippocampus. Neurosci Lett 1986;69:143-9.
25. McNamara JO. Role of neurotransmitters in seizure mechanisms in the kindling model of epilepsy. FASEB J 1984;43: 2516-20.
26. Kraus JE, Yeh G-C, Bonhaus DW, Nadler JV, McNamara JO. Kindling induces the long-lasting expression of a novel population of NMDA receptors in hippocampal region of CA3. J Neurosci 1994;14:4196-205.
27. Kohr G, DeKoninck Y, Mody I. Properties of NMDA receptor channels in neurons acutely isolated from epileptic (kindled) rats. J Neurosci 1993;13:3612-27.
28. McNamara JO, Russel RD, Rigsbee L, Bonhaus DW. Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models. Neuropharmacology 1988;22:562-8.
29. Bliss TVP, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant pathway. J Physiol (Lond) 1973;232:331-6.
30. Nicoll RA, Malenka RC. Contrasting properties of two forms of long-term potentiation in the hippocampus. Nature 1995;377:115-8.
31. Johnston HM, Morris BJ. NMDA and nitric oxide regulate the expression of calcium/calmodulin-dependent kinase II in the hippocampal dentate gyrus. Brain Res Mol Brain Res 1995;31:144-50.
32. Ghosh A, Greenberg ME. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 1995;268:239-46.
33. Gozlan H, Khazipov R, Ben-Air Y. Multiple forms of LTP and multiple regulatory sites of NMDA receptors: role of the redox site. J Neurobiol 1995;26:360-9.
34. Crair MC, Malanka RC. A critical period for long-term potentation at thalamocortical synapses. Nature 1995; 275:325-8.
35. Kirkwood A, Lee H-K, Bear MF. Co-regulation of long-term potentiation and experience-dependent synaptic plasticity in visual cortex by age and experience. Nature 1995; 375:328-31.
36. Fox K. The critical period for LTP in primary sensory cortex. Neuron 1995;15:485-8.
37. Jensen FE, Alvardo S, Firkusny I, Geary C. NBQX blocks acute and late epileptogenic effects of perinatal hypoxia. Epilepsia 1995;36:966-72.
38. Wuarin J-P, Kim YI, Cepeda C, et al. Synaptic transmission in human neocortex removed for treatment of intractable epilepsy in children. Ann Neurol 1990;28:503-10.
39. Avoli M, Olivier A. Bursting in human epileptogenic neocortex is depressed by an NMDA antagonist. Neurosci Lett 1987;76:249-54.
40. Sherwin A, Robitaille Y, Quesney F, et al. Excitatory amino acids are elevated in human epileptic cerebral cortex. Neurology 1988;38:920-3.
41. McDonald JW, Garofalo EA, Hood T, et al. Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy. Ann Neurol 1994;29:529-41.
42. Hosford DA, Crain BJ, Cao Z, et al. Increased AMPA-sensitive quisqualate receptor binding and reduced NMDA receptor binding in epileptic human hippocampus. J Neurosci 1991;11:428-34.
43. Rogers SW, Andrews PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994;265:648-51.
44. Twyman RE, Gahring LC, Spiess J, Rogers SW. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 1995;14:755-62.
45. Swann JW, Brady RJ, Martin DL. Postnatal development of GABA-mediated synaptic inhibition in rat hippocampus. Neuroscience 1989;28:551-61.
46. Ribak CF, Harris AB, Vaughan JE, Roberts E. Inhibitory GABAergic nerve terminals decrease at sites of focal epilepsy. Science 1979;205:211-4.
47. Babb TL, Pretorius JK, Kupfer WR, Crandall PH. Glutamate decarboxylase-immunoreactive neurons are preserved in human epileptic hippocampus. J Neurosci 1989;9:2562-74.
48. During MJ, Ryder KM, Spencer DD. Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature 1995; 376:174-7.
49. Velisek L, Veliskova J, Ptachewich T, Ortiz J, Shinnar S, Moshé SL. Age-dependent effects of gamma-aminobutyric acid agents on flurothyl seizures. Epilepsia 1995;36:636-43.
50. A agonists microinjected into rat substantial nigra: pro- and anticonvulsant actions. Epilepsia 1995;36:960-5.
51. A receptor. Science 1995;269:977-81.
52. Lambert N, Grover L. The mechanism of biphasic GABA responses. Science 1995;269:928-9.
53. Chauvel P, Trottier S. Role of noradrenergic ascending system in extinction of epileptic phenomena. In: DelgadoEscueta AV, Ward AA Jr, Woodbury DB, Porter RJ, eds. Basic mechanisms of the epilepsies: molecular and cellular approaches. New York: Raven Press, 1986:475-88. (Advances in neurology, vol. 44.)
54. Browning RA, Wade DR, Marcinczyk M, Long GL, Jobe PC. Regional brain abnormalities in norepinephrine uptake and dopamine beta-hydroxylase activity in the genetically epilepsy prone rat. J Pharmacol Exp Ther 1989;249:229-35.
55. Tsuda H, Ito M, Oguro K, et al. Involvement of the noradrenergic system in the seizures of the epileptic E1 mice. Eur J Pharmacol 1990;176:321-30.
56. Ferrendelli JA, Roles of biogenic amines and cyclic nucleotides in seizure mechanisms. Ann Neurol 1984;16(sup-pl):S98-103.
57. Alshuler HL, Killam EK, Killam KF. Biogenic amines in the photomyoclonic syndrome in the baboon, Papio papio. J Pharmacol Exp Ther 1976;196:156-66.
58. Noebels JL, Rutecki PA. Altered hippocampal network excitability in the hyperadrenergic mutant mouse tottering. Brain Res 1990;524:225-30.
59. Grutta VI, Sabatino M. Substantia nigra-mediated anticonvulsant action: a possible role of a dopaminergic component. Brain Res 1990;515:87-93.
60. Snead OC. Opiate induced seizures: a study of mu and specific mechanisms. Exp Neurol 1986;93:348-58.
61. Snead OC, Stephens H. The ontogeny of seizures induced by leucine enkephalin and beta-endorphin. Ann Neurol 1984; 14:594-8.
62. Houser CR, Mivashiro JA, Swartz BE, Walsh GO, Rich JR, Delgado-Escueta AV. Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J Neurosci 1990;10:267-82.
63. Frost JJ. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann Neurol 1988;23:231-7.
64. Johnston MV. Excitoticity of glutamate. In: Haddod, Lister, eds. Tissue oxygen deprivation. New York: Marcel Dekker, 1993.